155 related articles for article (PubMed ID: 26863859)
1. EFFECT OF HIV PREVENTION AND TREATMENT PROGRAM ON HIV AND HCV TRANSMISSION AND HIV MORTALITY AT AN INDONESIAN NARCOTIC PRISON.
Nelwan EJ; Indrati AK; Isa A; Triani N; Alam NN; Herlan MS; Husen W; Pohan HT; Alisjahbana B; Meheus A; Van Crevel R; van der Ven AJ
Southeast Asian J Trop Med Public Health; 2015 Sep; 46(5):880-91. PubMed ID: 26863859
[TBL] [Abstract][Full Text] [Related]
2. Injecting drug use, sexual risk, HIV knowledge and harm reduction uptake in a large prison in Bali, Indonesia.
Sawitri AA; Hartawan AA; Craine N; Sari AK; Septarini NW; Wirawan DN
Int J Prison Health; 2016; 12(1):27-38. PubMed ID: 26933990
[TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus, hepatitis B and hepatitis C in an Indonesian prison: prevalence, risk factors and implications of HIV screening.
Nelwan EJ; Van Crevel R; Alisjahbana B; Indrati AK; Dwiyana RF; Nuralam N; Pohan HT; Jaya I; Meheus A; Van Der Ven A
Trop Med Int Health; 2010 Dec; 15(12):1491-8. PubMed ID: 20955370
[TBL] [Abstract][Full Text] [Related]
4. Within-prison drug injection among HIV-infected male prisoners in Indonesia: a highly constrained choice.
Culbert GJ; Waluyo A; Iriyanti M; Muchransyah AP; Kamarulzaman A; Altice FL
Drug Alcohol Depend; 2015 Apr; 149():71-9. PubMed ID: 25659895
[TBL] [Abstract][Full Text] [Related]
5. Violence and hepatitis C transmission in prison-A modified social ecological model.
Sazzad HMS; McCredie L; Treloar C; Lloyd AR; Lafferty L
PLoS One; 2020; 15(12):e0243106. PubMed ID: 33259565
[TBL] [Abstract][Full Text] [Related]
6. Correlation between HIV and HCV in Brazilian prisoners: evidence for parenteral transmission inside prison.
Burattini M; Massad E; Rozman M; Azevedo R; Carvalho H
Rev Saude Publica; 2000 Oct; 34(5):431-6. PubMed ID: 11105105
[TBL] [Abstract][Full Text] [Related]
7. Tattooing in prisons--not such a pretty picture.
Hellard ME; Aitken CK; Hocking JS
Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561
[TBL] [Abstract][Full Text] [Related]
8. People who inject drugs in prison: HIV prevalence, transmission and prevention.
Dolan K; Moazen B; Noori A; Rahimzadeh S; Farzadfar F; Hariga F
Int J Drug Policy; 2015 Feb; 26 Suppl 1():S12-5. PubMed ID: 25727258
[TBL] [Abstract][Full Text] [Related]
9. Incidence and correlates of hepatitis C virus infection in a large cohort of prisoners who have injected drugs.
Snow KJ; Young JT; Preen DB; Lennox NG; Kinner SA
BMC Public Health; 2014 Aug; 14():830. PubMed ID: 25113132
[TBL] [Abstract][Full Text] [Related]
10. Indonesian prisons and HIV: part of the problem, part of the solution?
Nelwan EJ; Diana A; van Crevel R; Alam NN; Alisjahbana B; Pohan HT; van der Ven A; Djaya I
Acta Med Indones; 2009 Jul; 41 Suppl 1():52-6. PubMed ID: 19920299
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus infection in South Australian prisoners: seroprevalence, seroconversion, and risk factors.
Miller ER; Bi P; Ryan P
Int J Infect Dis; 2009 Mar; 13(2):201-8. PubMed ID: 18790659
[TBL] [Abstract][Full Text] [Related]
12. High rates of drug use, but low rates of HIV risk behaviours among injecting drug users during incarceration in Dutch prisons.
van Haastrecht HJ; Bax JS; van den Hoek AA
Addiction; 1998 Sep; 93(9):1417-25. PubMed ID: 9926547
[TBL] [Abstract][Full Text] [Related]
13. Drug use and risk of bloodborne infections: a survey of female prisoners in British Columbia.
Martin RE; Gold F; Murphy W; Remple V; Berkowitz J; Money D
Can J Public Health; 2005; 96(2):97-101. PubMed ID: 15850026
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey.
Weild AR; Gill ON; Bennett D; Livingstone SJ; Parry JV; Curran L
Commun Dis Public Health; 2000 Jun; 3(2):121-6. PubMed ID: 10902255
[TBL] [Abstract][Full Text] [Related]
15. High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).
Wenz B; Nielsen S; Gassowski M; Santos-Hövener C; Cai W; Ross RS; Bock CT; Ratsch BA; Kücherer C; Bannert N; Bremer V; Hamouda O; Marcus U; Zimmermann R;
BMC Public Health; 2016 Sep; 16(1):927. PubMed ID: 27595567
[TBL] [Abstract][Full Text] [Related]
16. Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study.
Cunningham EB; Hajarizadeh B; Bretana NA; Amin J; Betz-Stablein B; Dore GJ; Luciani F; Teutsch S; Dolan K; Lloyd AR; Grebely J;
J Viral Hepat; 2017 Sep; 24(9):733-741. PubMed ID: 28256027
[TBL] [Abstract][Full Text] [Related]
17. Methadone within prison and linkage to and retention in treatment upon community release for people with opioid use disorder in Kyrgyzstan: Evaluation of a national program.
Bachireddy C; Shrestha R; Bromberg DJ; Azbel L; Kurmanalieva A; Wegman M; Shumskaya N; Rozanova J; Meyer JP; Altice FL
Int J Drug Policy; 2022 Mar; 101():103558. PubMed ID: 34915426
[TBL] [Abstract][Full Text] [Related]
18. HIV and hepatitis C prevalence, and related risk behaviours among people who inject drugs in three cities in Croatia: Findings from respondent-driven sampling surveys.
Handanagic S; Bozicevic I; Civljak M; Dominkovic Z; Sevic S; Barbaric J; Nemeth Blazic T; Dakovic Rode O; Begovac J
Int J Drug Policy; 2016 Jun; 32():57-63. PubMed ID: 27160504
[TBL] [Abstract][Full Text] [Related]
19. Survey of risk behaviour and HIV prevalence in an English prison.
Edwards A; Curtis S; Sherrard J
Int J STD AIDS; 1999 Jul; 10(7):464-6. PubMed ID: 10454182
[TBL] [Abstract][Full Text] [Related]
20. Spread of bloodborne viruses among Australian prison entrants.
Crofts N; Stewart T; Hearne P; Ping XY; Breshkin AM; Locarnini SA
BMJ; 1995 Feb; 310(6975):285-8. PubMed ID: 7866168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
